J B Chemicals and Pharmaceuticals
add_icon

J B Chemicals and Pharmaceuticals

1,846.00
-55.60
(-2.92%)
Market Cap
28,917.77 Cr
PE Ratio
40.46
Volume
1,32,508.00
Day High - Low
1,907.00 - 1,833.80
52W High-Low
1,939.00 - 1,385.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
28,917.77 Cr
EPS
42.45
PE Ratio
40.46
PB Ratio
8.01
Book Value
237.24
EBITDA
1,070.20
Dividend Yield
0.79 %
Industry
Healthcare
Return on Equity
19.21
Debt to Equity
0.06
Analyst Rating and Forecast
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+55.56 %
+55.56 %
Hold
Hold+44.44 %
+44.44 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
J.B. Chemicals & Pharmaceuticals corrects date error in board meeting outcome regarding Tau Investment Holdings' request to reclassify from promoter to public category under SEBI regulations.
neutral
Torrent Pharmaceuticals acquires 46.39% stake in JB Chemicals for control, triggering board restructuring with multiple director resignations including CEO Nikhil Chopra.
positive
J.B. Chemicals & Pharmaceuticals allotted 37,84,100 equity shares to employees under stock option scheme, raising ₹183.20 crores and increasing paid-up capital to 16.04 crore shares.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,631.90
#1 3,91,547.47
37.40
#1 54,729.00
9.71
#1 10,980
2.89
32.48
6,011.50
1,59,586.44
64.87
9,712.00
18.67
2,191
35.10
31.96
3,932.20
1,33,083.52
63.64
11,539.40
6.99
1,911
30.46
51.26
1,315.00
1,06,221.99
20.39
28,409.50
7.12
5,291
3.71
16.66
1,235.60
1,03,126.93
18.39
33,741.20
16.73
5,725
-15.28
53.53
2,137.20
97,627.04
22.75
22,909.50
13.74
3,306
#1 72.75
49.85
882.00
88,749.84
#1 17.70
23,511.00
18.55
4,615
34.60
39.82
2,107.60
87,002.80
49.98
12,744.20
#1 20.90
2,007
-21.05
41.23
5,750.50
68,755.85
28.60
13,458.30
3.70
2,216
10.98
54.24
1,132.50
65,775.78
19.45
32,345.60
9.43
3,484
3.81
37.32
Growth Rate
Revenue Growth
12.35 %
Net Income Growth
19.36 %
Cash Flow Change
12.72 %
ROE
1.64 %
ROCE
-3.02 %
EBITDA Margin (Avg.)
1.96 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
408
444
398
435
459
475
445
447
545
452
604
554
619
613
605
627
786
811
796
767
902
889
852
878
1,010
1,011
972
964
1,109
1,100
1,083
Expenses
326
354
304
353
350
356
339
362
367
334
377
405
442
466
473
500
612
625
618
599
664
638
621
664
724
730
709
723
793
775
769
EBITDA
82
90
94
81
109
119
106
85
178
119
227
149
177
146
133
127
174
186
178
168
238
251
231
215
286
281
263
241
315
325
314
Operating Profit %
20 %
19 %
20 %
16 %
22 %
22 %
21 %
18 %
30 %
25 %
31 %
23 %
27 %
21 %
21 %
20 %
22 %
23 %
22 %
21 %
26 %
28 %
26 %
23 %
28 %
27 %
26 %
24 %
28 %
29 %
28 %
Depreciation
15
15
15
12
16
16
17
17
17
18
17
17
18
16
17
22
26
28
28
32
31
32
34
41
41
42
42
46
43
44
45
Interest
1
1
1
1
1
1
1
1
4
2
1
1
1
1
1
2
6
8
8
14
12
10
13
9
6
2
3
2
1
1
2
Profit Before Tax
66
75
78
68
92
102
88
67
157
99
209
132
158
129
114
103
142
150
141
123
194
209
184
165
240
237
218
193
272
279
267
Tax
21
23
28
22
30
8
22
17
38
25
54
31
39
32
30
18
37
39
35
35
52
58
50
38
63
62
56
47
69
71
69
Net Profit
46
52
50
47
62
94
66
50
120
74
154
101
119
98
84
85
105
111
106
88
142
151
134
126
177
175
163
146
202
208
198
EPS in ₹
5.46
6.14
6.07
5.68
7.73
11.67
8.26
6.30
15.45
9.55
19.94
13.02
15.38
12.65
10.85
10.98
13.59
14.37
13.72
11.33
9.20
9.72
8.62
8.22
11.39
11.24
10.46
9.36
12.99
13.29
12.63

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,487
1,648
1,674
1,765
1,792
1,821
2,238
2,607
3,554
3,994
4,274
Fixed Assets
329
440
679
640
621
651
634
1,277
1,901
2,004
1,968
Current Assets
901
816
795
1,047
1,051
1,073
1,553
1,253
1,528
1,853
1,923
Capital Work in Progress
55
135
4
17
15
16
26
19
55
76
63
Investments
367
479
411
434
457
403
678
13
206
388
345
Other Assets
737
594
580
674
699
750
901
1,299
1,392
1,525
1,897
Total Liabilities
1,487
1,648
1,674
1,765
1,792
1,821
2,238
2,607
3,554
3,994
4,274
Current Liabilities
460
431
281
275
244
313
345
384
554
868
632
Non Current Liabilities
33
31
27
46
65
69
79
85
519
203
208
Total Equity
995
1,186
1,366
1,444
1,483
1,438
1,813
2,139
2,480
2,923
3,433
Reserve & Surplus
978
1,167
1,347
1,425
1,464
1,420
1,794
2,119
2,465
2,908
3,418
Share Capital
17
17
17
17
16
16
16
16
16
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
13
15
-28
43
11
-6
-3
34
20
11
27
Investing Activities
-112
-26
-45
-21
-28
24
-231
2
-962
-404
-296
Operating Activities
127
140
201
123
194
276
315
170
626
801
903
Financing Activities
-1
-100
-184
-60
-156
-306
-87
-138
357
-386
-580

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
55.91 %
55.91 %
55.91 %
54.00 %
54.00 %
54.00 %
53.96 %
53.95 %
53.93 %
53.91 %
53.86 %
53.83 %
53.78 %
53.77 %
53.74 %
53.66 %
47.84 %
47.73 %
47.56 %
47.55 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.05 %
0.00 %
11.06 %
12.17 %
13.63 %
14.64 %
18.30 %
17.77 %
15.30 %
14.88 %
DIIs
12.41 %
12.32 %
14.76 %
16.03 %
16.67 %
17.52 %
18.08 %
18.54 %
19.08 %
18.65 %
18.58 %
17.97 %
18.38 %
17.62 %
16.81 %
16.41 %
18.72 %
19.63 %
22.83 %
23.36 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.50 %
19.69 %
17.64 %
18.38 %
17.87 %
17.37 %
16.94 %
16.70 %
15.98 %
15.66 %
15.34 %
15.17 %
14.69 %
14.38 %
13.87 %
13.42 %
13.28 %
13.04 %
12.47 %
12.37 %
Others
11.18 %
12.08 %
11.70 %
11.58 %
11.47 %
11.10 %
11.02 %
10.81 %
11.00 %
11.79 %
2.17 %
13.03 %
2.09 %
2.05 %
1.94 %
1.87 %
1.86 %
1.83 %
1.84 %
1.85 %
No of Share Holders
0
65,715
70,740
71,788
64,861
61,314
60,268
58,629
56,633
55,965
60,817
63,230
63,892
66,953
62,743
62,081
63,948
70,064
71,957
69,338

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1 2 5 11 16.5 16.5 17.75 12.25 15.5 0.00
Dividend Yield (%) 0.64 1.1 1.96 1.75 2.1 1.67 1.08 0.75 0.84 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
22 Feb 2021 DIVIDEND Dividend
₹ 8.50 /share
18 Feb 2021 520.90 555.25
02 Sept 2021 DIVIDEND Dividend
₹ 8.00 /share
01 Sept 2021 770.03 850.15
24 Feb 2022 DIVIDEND Dividend
₹ 8.50 /share
23 Feb 2022 852.88 804.93
17 Aug 2022 DIVIDEND Dividend
₹ 8.00 /share
12 Aug 2022 785.18 931.68
18 Feb 2023 DIVIDEND Dividend
₹ 8.50 /share
17 Feb 2023 1,008.50 982.73
17 Aug 2023 DIVIDEND Dividend
₹ 9.25 /share
17 Aug 2023 976.00 1,315.08
24 May 2023 SPLIT Split
1:2
18 Sept 2023 976.00 976.00
16 Feb 2024 DIVIDEND Dividend
₹ 5.50 /share
16 Feb 2024 1,708.40 1,664.30
14 Aug 2024 DIVIDEND Dividend
₹ 6.75 /share
14 Aug 2024 1,832.55 1,941.60
21 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Aug 2024 1,788.80 1,942.60
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 1,895.75 1,852.00
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,805.05 1,714.10
08 Feb 2025 DIVIDEND Dividend
₹ 8.50 /share
07 Feb 2025 1,714.10 1,673.75
14 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 May 2025 1,658.70 1,579.85
30 Jul 2025 DIVIDEND Dividend
₹ 7.00 /share
30 Jul 2025 1,579.85 1,802.60
30 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2025 1,651.85 1,802.60
06 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Aug 2025 1,612.55 1,692.45
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 1,708.80 1,813.40
16 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 Jan 2026 1,818.60 1,894.20

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20111 day ago
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.1 day ago
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 20113 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome3 days ago
Corrigendum To The Outcome Of The First Board Meeting Held On 21 January 20263 days ago
Disclosure Under Regulation 31A(10)(Ii) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations").4 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate4 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On 21 January 20264 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome6 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation8 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors8 days ago
Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 07, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 05, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of OrderDec 30, 2025
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter And Nine Months Ending On December 31 2025Dec 29, 2025
Closure of Trading WindowDec 29, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 24, 2025
DJSI (Dow Jones Sustainable Index) ESG Score ReleaseDec 22, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Receipt Of OrderDec 16, 2025
Updates on Open OfferDec 09, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 06, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 23, 2025
Updates on Open OfferNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 14, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 11, 2025
Letter of OfferNov 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2025
4Th Sustainability (ESG) ReportOct 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 24, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025.Oct 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Closure of Trading WindowSep 30, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 08, 2025
Updates on Open OfferSep 04, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 01, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 31, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 14, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Kotak Small Cap Fund Direct-Growth
0.82%
-519400
-0.50%
-0.39%
Baroda BNP Paribas Small Cap Fund Direct - Growth
1.47%
98441
1.47%
1.47%
WhiteOak Capital Special Opportunities Fund Direct - Growth
2.88%
90364
1.16%
1.24%
WhiteOak Capital Flexi Cap Fund Direct - Growth
1.29%
64898
0.16%
0.49%
Helios Mid Cap Fund Direct-Growth
1.57%
58553
0.38%
0.88%
ITI Small Cap Fund Direct-Growth
1.21%
35602
0.27%
0.32%
Canara Robeco Equity Hybrid Fund Direct-Growth
0.58%
32000
0.07%
0.14%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
8.38%
27660
1.09%
1.90%
Mirae Asset Healthcare Fund Direct - Growth
3.10%
23000
0.27%
0.42%
Axis Equity Savings Fund Direct-Growth
0.62%
-14490
-0.26%
-0.60%
Mirae Asset Multi Asset Allocation Fund Direct - Growth
0.35%
10000
0.05%
0.05%
WhiteOak Capital Quality Equity Fund Direct-Growth
2.63%
7363
0.25%
0.86%
Union Small Cap Fund Direct-Growth
1.88%
5298
0.14%
0.24%
WhiteOak Capital Equity Savings Fund Direct - Growth
0.36%
1771
0.12%
0.10%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.74%
1451
0.02%
0.08%
DSP Nifty Smallcap250 Quality 50 Index Fund Direct - Growth
2.75%
1326
0.14%
0.34%
Kotak Nifty Smallcap 50 Index Fund Direct - Growth
1.99%
1056
0.08%
0.21%
LIC MF Manufacturing Fund Direct-Growth
0.79%
-1038
0.03%
0.11%
Baroda BNP Paribas Value Fund Direct - Growth
1.54%
-1000
0.05%
0.15%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.20%
-890
-0.01%
0.00%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.74%
778
0.02%
0.08%
Axis Nifty Smallcap 50 Index Fund Direct-Growth
1.98%
488
0.07%
0.20%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.74%
-470
0.02%
0.08%
Bandhan Focused Fund Direct-Growth
1.87%
-424
0.07%
-0.40%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.07%
324
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
48.03
ATR(14)
Volatile
38.70
STOCH(9,6)
Neutral
51.67
STOCH RSI(14)
Oversold
5.17
MACD(12,26)
Bearish
-4.36
ADX(14)
Strong Trend
25.73
UO(9)
Bearish
54.28
ROC(12)
Downtrend And Accelerating
-1.71
WillR(14)
Oversold
-88.40

About J B Chemicals and Pharmaceuticals

J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands...more
Chairperson NameArun Duggal